Pictet Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Pictet Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,400	Closed	-$257K	–	69
2021 Q2	$257K	Hold	1,400	–	–	0.14%	62
2021 Q1	$214K	Hold	1,400	–	–	0.13%	58
2020 Q4	$219K	Buy	+1,400	New	+$180K	0.14%	59
2020 Q2	–	Sell	-3,000	Closed	-$269K	–	63
2020 Q1	$269K	Sell	3,000 -1,050	-26%	-$103K	0.15%	58
2019 Q4	$438K	Hold	4,050	–	–	0.17%	59
2019 Q3	$397K	Hold	4,050	–	–	0.17%	57
2019 Q2	$530K	Hold	4,050	–	–	0.23%	56
2019 Q1	$547K	Sell	4,050 -2,800	-41%	-$348K	0.24%	54
2018 Q4	$667K	Hold	6,850	–	–	0.27%	59
2018 Q3	$952K	Hold	6,850	–	–	0.3%	53
2018 Q2	$850K	Hold	6,850	–	–	0.29%	52
2018 Q1	$764K	Hold	6,850	–	–	0.27%	53
2017 Q4	$819K	Sell	6,850 -600	-8%	-$73.1K	0.24%	61
2017 Q3	$1.04M	Hold	7,450	–	–	0.31%	54
2017 Q2	$906K	Buy	+7,450	New	+$867K	0.29%	61

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Pictet Bank & Trust's ALXN Position: Q3 2021 in Review

Pictet Bank & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,400 shares — an estimated $257K sold.

Pictet Bank & Trust first reported a position in ALXN in Q2 2017 and held it in 15 quarters. The position peaked at $1.04M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Pictet Bank & Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Pictet Bank & Trust sold 1,400 Alexion Pharmaceuticals shares in Q3 2021, an estimated $257K.
Pictet Bank & Trust first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 15 quarters.
Pictet Bank & Trust's Alexion Pharmaceuticals position peaked at $1.04M in Q3 2017.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Pictet Bank & Trust's 13F filing for Q3 2021, filed 10 Nov 2021.